Evidence map›Paper›PMID 27702897›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Real-time analysis of RAG complex activity in V(D)J recombination.

Jennifer Zagelbaum, Noriko Shimazaki, Zitadel Anne Esguerra, Go Watanabe, Michael R Lieber, Eli Rothenberg

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. A novelBlood · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jennifer ZagelbaumDepartment of Biochemistry and Molecular Pharmacology, Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016.
Noriko ShimazakiDepartment of Pathology, University of Southern California (USC) Keck School of Medicine, USC Norris Comprehensive Cancer Center, Los Angeles, CA 90033; Department of Biochemistry & Molecular Biology, University of Southern California (USC) Keck School of Medicine, USC Norris Comprehensive Cancer Center, Los Angeles, CA 90033; Department of Molecular Microbiology & Immunology, University of Southern California (USC) Keck School of Medicine, USC Norris Comprehensive Cancer Center, Los Angeles, CA 90033; Section of Molecular & Computational Biology, Department of Biological Sciences, University of Southern California (USC), Los Angeles, CA 90089.
Zitadel Anne EsguerraDepartment of Pathology, University of Southern California (USC) Keck School of Medicine, USC Norris Comprehensive Cancer Center, Los Angeles, CA 90033; Department of Biochemistry & Molecular Biology, University of Southern California (USC) Keck School of Medicine, USC Norris Comprehensive Cancer Center, Los Angeles, CA 90033; Department of Molecular Microbiology & Immunology, University of Southern California (USC) Keck School of Medicine, USC Norris Comprehensive Cancer Center, Los Angeles, CA 90033; Section of Molecular & Computational Biology, Department of Biological Sciences, University of Southern California (USC), Los Angeles, CA 90089.
Go WatanabeDepartment of Pathology, University of Southern California (USC) Keck School of Medicine, USC Norris Comprehensive Cancer Center, Los Angeles, CA 90033; Department of Biochemistry & Molecular Biology, University of Southern California (USC) Keck School of Medicine, USC Norris Comprehensive Cancer Center, Los Angeles, CA 90033; Department of Molecular Microbiology & Immunology, University of Southern California (USC) Keck School of Medicine, USC Norris Comprehensive Cancer Center, Los Angeles, CA 90033; Section of Molecular & Computational Biology, Department of Biological Sciences, University of Southern California (USC), Los Angeles, CA 90089.ORCID 0000-0003-3911-3021
Michael R LieberDepartment of Pathology, University of Southern California (USC) Keck School of Medicine, USC Norris Comprehensive Cancer Center, Los Angeles, CA 90033; Department of Biochemistry & Molecular Biology, University of Southern California (USC) Keck School of Medicine, USC Norris Comprehensive Cancer Center, Los Angeles, CA 90033; Department of Molecular Microbiology & Immunology, University of Southern California (USC) Keck School of Medicine, USC Norris Comprehensive Cancer Center, Los Angeles, CA 90033; Section of Molecular & Computational Biology, Department of Biological Sciences, University of Southern California (USC), Los Angeles, CA 90089 eli.rothenberg@nyumc.org lieber@usc.edu.
Eli RothenbergDepartment of Biochemistry and Molecular Pharmacology, Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016; eli.rothenberg@nyumc.org lieber@usc.edu.
University of Southern California · USNew York University · US

Funding

MECHANISM AND REGULATION OF NONHOMOLOGOUS DNA ENDJOININGR01CA100504 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LIEBER, MICHAEL R · 2003 to 2021
$5.0M
Site-Specific Recombination in Human Health & DiseaseR35GM118009 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LIEBER, MICHAEL R · 2016 to 2025
$4.4M
NORMAL AND MUTANT LYMPHOID VDJ RECOMBINASER01GM043236 · NIGMS · WASHINGTON UNIVERSITY · PI LIEBER, MICHAEL R · 1990 to 2015
$2.6M
Mechanisms of Human Lymphoid Chromosomal TranslocationR01CA196671 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LIEBER, MICHAEL R · 2016 to 2021
$1.9M
Single-Molecule Studies of Non-Homologous DNA End JoiningR01GM108119 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ROTHENBERG, ELI · 2015 to 2019
$1.7M
Single-molecule studies of BRCA1-BACH1 mechanism in genomic integrityR21CA187612 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ROTHENBERG, ELI · 2015 to 2016
$451k
6 · The paper itself

Abstract

Single-molecule FRET (smFRET) and single-molecule colocalization (smCL) assays have allowed us to observe the recombination-activating gene (RAG) complex reaction mechanism in real time. Our smFRET data have revealed distinct bending modes at recombination signal sequence (RSS)-conserved regions before nicking and synapsis. We show that high mobility group box 1 (HMGB1) acts as a cofactor in stabilizing conformational changes at the 12RSS heptamer and increasing RAG1/2 binding affinity for 23RSS. Using smCL analysis, we have quantitatively measured RAG1/2 dwell time on 12RSS, 23RSS, and non-RSS DNA, confirming a strict RSS molecular specificity that was enhanced in the presence of a partner RSS in solution. Our studies also provide single-molecule determination of rate constants that were previously only possible by indirect methods, allowing us to conclude that RAG binding, bending, and synapsis precede catalysis. Our real-time analysis offers insight into the requirements for RSS-RSS pairing, architecture of the synaptic complex, and dynamics of the paired RSS substrates. We show that the synaptic complex is extremely stable and that heptamer regions of the 12RSS and 23RSS substrates in the synaptic complex are closely associated in a stable conformational state, whereas nonamer regions are perpendicular. Our data provide an enhanced and comprehensive mechanistic description of the structural dynamics and associated enzyme kinetics of variable, diversity, and joining [V(D)J] recombination.

Indexed as

V(D)J RecombinationAnimalsCatalysisDNADNA-Binding ProteinsDNA CleavageFluorescence Resonance Energy TransferHMGB1 ProteinHomeodomain ProteinsKineticsMarkov ChainsMiceModels, MolecularMolecular ConformationMultiprotein ComplexesNucleic Acid ConformationDNADNA-Binding ProteinsHMGB1 ProteinHomeodomain ProteinsMultiprotein ComplexesRAG-1 proteinRag2 protein, mouseantigen receptor geneimmunoglobulinrecombination-activating genesingle-molecule FRETV(D)J recombination

Identifiers

PMID27702897
PMCPMC5081608
OpenAlexW2528408357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.